UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT
TO SECTION 12(b) OR (g) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Acura
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
|
New
York
|
11-0853640
|
|
(State
of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
|
616
N. North Court, Suite 120, Palatine, Illinois
|
60067
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Securities
to be registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
Name
of each exchange on which
|
|
|
to
be so registered
|
each
class is to be registered
|
|
|
Common
Stock
|
The
Nasdaq Stock Market LLC
|
|
|
Par
Value, $.01 Per Share
|
|
|
|
|
|
|
If
this
form relates to the registration of a class of securities pursuant to Section
12(b) of the Exchange Act and is effective pursuant to General Instruction
A.(c), check the following box. x
If
this
form relates to the registration of a class of securities pursuant to Section
12(g) of the Exchange Act and is effective pursuant to general Instruction
A.(d), check the following box. o
Securities
Act registration statement file number to which this form relates:
______________ (if applicable)
Securities
to be registered pursuant to Section 12(g) of the Act:
|
(Title
of class)
|
|
(Title
of
class)
|
INFORMATION
REQUIRED IN REGISTRATION STATEMENT
Item
1. Description of Registrant's Securities to be
Registered.
A
description of the Registrant's capital stock being registered is as follows:
common stock, $.01 par value (the “Common Stock”).
Dividend
Rights.
Subject
to the dividend rights of any outstanding shares of preferred stock (the
“Preferred Stock”), the holders of Common Stock shall be entitled to receive,
as, when and if declared by the board of directors (the “Board”) of the
Registrant, but only out of funds legally available therefor, cash dividends
in
such amounts as the Board may determine.
Voting
Rights.
Each
share of Common Stock entitles the holder thereof to one vote on each matter
submitted to a vote of the stockholders of the Registrant.
Liquidation
Rights.
In the
event of any liquidation, dissolution or winding up of the Registrant, whether
voluntary or involuntary, after payment or provision for payment of debts and
other liabilities of the Registrant and the preferential amounts to which the
holders of any outstanding shares of Preferred Stock shall be entitled to
receive upon dissolution, liquidation, or winding up, the holders of Common
Stock shall be entitled to share on a share for share basis in the remaining
assets of the Registrant.
Item
2. Exhibits.
Pursuant
to the instructions, no exhibits are required to be filed.
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the
registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereto duly authorized.
| (Registrant) | Acura Pharmaceuticals, Inc. |
| Date: | January 31, 2008 | |||
| By: | /s/ Peter A. Clemens | |||
|
Peter
A. Clemens,
Senior
Vice President and Chief Financial Officer
|
||||